Patrick F. Smith

Insider Reports History

Entity
Individual
Location
C/O Certara, Inc., 100 Overlook Center, Suite 101, Princeton, NJ
Signature
/s/ Daniel Corcoran, Attorney-In-Fact for Patrick F. Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick F. Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Certara, Inc. PRESIDENT, DRUG DEV SOLUTIONS Common Stock 50.1K $553K $11.03 Oct 7, 2024 Direct
Certara, Inc. PRESIDENT, DRUG DEV SOLUTIONS Restricted Stock Units 14.3K $161K $11.29 Oct 4, 2024 Direct

Insider Reports Filed by Patrick F. Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERT Certara, Inc. Oct 7, 2024 1 -$59.7K 4 Oct 8, 2024 PRESIDENT, DRUG DEV SOLUTIONS
CERT Certara, Inc. Oct 4, 2024 3 -$19.1K 4 Oct 7, 2024 PRESIDENT, DRUG DEV SOLUTIONS
CERT Certara, Inc. Apr 2, 2024 6 -$243K 4 Apr 4, 2024 PRESIDENT, DRUG DEV SOLUTIONS
CERT Certara, Inc. Apr 1, 2024 8 -$124K 4 Apr 3, 2024 PRESIDENT, DRUG DEV SOLUTIONS
CERT Certara, Inc. Feb 20, 2024 1 -$90K 4 Feb 21, 2024 PRESIDENT, DRUG DEV SOLUTIONS
CERT Certara, Inc. Oct 5, 2023 1 $0 4 Oct 6, 2023 PRESIDENT, DRUG DEV SOLUTIONS
CERT Certara, Inc. Jun 5, 2023 1 -$412K 4 Jun 6, 2023 PRESIDENT, INTEGRATED DRUG DEV
CERT Certara, Inc. Mar 31, 2023 5 -$105K 4 Apr 3, 2023 PRESIDENT, INTEGRATED DRUG DEV
CERT Certara, Inc. Nov 9, 2022 1 -$32.2K 4 Nov 14, 2022 PRESIDENT, INTEGRATED DRUG DEV
CERT Certara, Inc. Nov 1, 2022 1 -$15.2K 4 Nov 2, 2022 PRESIDENT, INTEGRATED DRUG DEV
CERT Certara, Inc. Aug 16, 2022 1 -$177K 4 Aug 18, 2022 PRESIDENT, INTEGRATED DRUG DEV
CERT Certara, Inc. Jun 8, 2022 1 -$192K 4 Jun 9, 2022 PRESIDENT, INTEGRATED DRUG DEV
CERT Certara, Inc. Apr 1, 2022 3 -$108K 4 Apr 5, 2022 PRESIDENT, INTEGRATED DRUG DEV
CERT Certara, Inc. Nov 1, 2021 1 $0 4 Nov 1, 2021 PRESIDENT, INTEGRATED DRUG DEV
CERT Certara, Inc. Nov 1, 2021 0 $0 3 Nov 1, 2021 PRESIDENT, INTEGRATED DRUG DEV